The R&D in utilising Kainitite for SOP will be done by Yara.
The "spin-off" or off-take on Kainitite will provide the Equity portion of the financing for the MOP project (recipient for the either alternative on SOP will be Yara)
So far so good, because it strengthens Allana's over all business model and position against ICL. And will potentially reduce dilution of the current shareholders dramatically.
The flip side is that nothing will happen for 6 months. (low twenties here we come, but at least it does not look like a permanent capital loss here)
IMHO
PEA Q1/15
Potential Spin-off and equity financing Q1/15
This is a path to be followed, if no spin-off to Yara)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.